Titre : Vaccins antiviraux

Vaccins antiviraux : Questions médicales fréquentes

Termes MeSH sélectionnés :

Policy Making
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vaccins antiviraux : Questions médicales les plus fréquentes", "headline": "Vaccins antiviraux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vaccins antiviraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-24", "dateModified": "2025-02-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vaccins antiviraux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vaccins", "url": "https://questionsmedicales.fr/mesh/D014612", "about": { "@type": "MedicalCondition", "name": "Vaccins", "code": { "@type": "MedicalCode", "code": "D014612", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccins anti-adénovirus", "alternateName": "Adenovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D062705", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-adénovirus", "code": { "@type": "MedicalCode", "code": "D062705", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.024" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre le SIDA", "alternateName": "AIDS Vaccines", "url": "https://questionsmedicales.fr/mesh/D016915", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le SIDA", "code": { "@type": "MedicalCode", "code": "D016915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.050" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la COVID-19", "alternateName": "COVID-19 Vaccines", "url": "https://questionsmedicales.fr/mesh/D000086663", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la COVID-19", "code": { "@type": "MedicalCode", "code": "D000086663", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin ChAdOx1 nCoV-19", "alternateName": "ChAdOx1 nCoV-19", "url": "https://questionsmedicales.fr/mesh/D000090985", "about": { "@type": "MedicalCondition", "name": "Vaccin ChAdOx1 nCoV-19", "code": { "@type": "MedicalCode", "code": "D000090985", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085.063" } } }, { "@type": "MedicalWebPage", "name": "Ad26COVS1", "alternateName": "Ad26COVS1", "url": "https://questionsmedicales.fr/mesh/D000090984", "about": { "@type": "MedicalCondition", "name": "Ad26COVS1", "code": { "@type": "MedicalCode", "code": "D000090984", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085.125" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le cytomégalovirus", "alternateName": "Cytomegalovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022482", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le cytomégalovirus", "code": { "@type": "MedicalCode", "code": "D022482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.120" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la dengue", "alternateName": "Dengue Vaccines", "url": "https://questionsmedicales.fr/mesh/D053059", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la dengue", "code": { "@type": "MedicalCode", "code": "D053059", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.162" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie à virus Ebola", "alternateName": "Ebola Vaccines", "url": "https://questionsmedicales.fr/mesh/D046129", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie à virus Ebola", "code": { "@type": "MedicalCode", "code": "D046129", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.205" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les herpèsvirus", "alternateName": "Herpesvirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022283", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les herpèsvirus", "code": { "@type": "MedicalCode", "code": "D022283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre la varicelle", "alternateName": "Chickenpox Vaccine", "url": "https://questionsmedicales.fr/mesh/D019433", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la varicelle", "code": { "@type": "MedicalCode", "code": "D019433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre le zona", "alternateName": "Herpes Zoster Vaccine", "url": "https://questionsmedicales.fr/mesh/D053061", "about": { "@type": "MedicalCondition", "name": "Vaccin contre le zona", "code": { "@type": "MedicalCode", "code": "D053061", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccin contre le zona", "alternateName": "Herpes Zoster Vaccine", "url": "https://questionsmedicales.fr/mesh/D053061", "about": { "@type": "MedicalCondition", "name": "Vaccin contre le zona", "code": { "@type": "MedicalCode", "code": "D053061", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130.400" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus herpès simplex", "alternateName": "Herpes Simplex Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022301", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus herpès simplex", "code": { "@type": "MedicalCode", "code": "D022301", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.400" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie de Marek", "alternateName": "Marek Disease Vaccines", "url": "https://questionsmedicales.fr/mesh/D022501", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie de Marek", "code": { "@type": "MedicalCode", "code": "D022501", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins antigrippaux", "alternateName": "Influenza Vaccines", "url": "https://questionsmedicales.fr/mesh/D007252", "about": { "@type": "MedicalCondition", "name": "Vaccins antigrippaux", "code": { "@type": "MedicalCode", "code": "D007252", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.302" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre l'encéphalite japonaise", "alternateName": "Japanese Encephalitis Vaccines", "url": "https://questionsmedicales.fr/mesh/D022321", "about": { "@type": "MedicalCondition", "name": "Vaccins contre l'encéphalite japonaise", "code": { "@type": "MedicalCode", "code": "D022321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.320" } } }, { "@type": "MedicalWebPage", "name": "Vaccin contre la rougeole", "alternateName": "Measles Vaccine", "url": "https://questionsmedicales.fr/mesh/D008458", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la rougeole", "code": { "@type": "MedicalCode", "code": "D008458", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.404" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antiourlien", "alternateName": "Mumps Vaccine", "url": "https://questionsmedicales.fr/mesh/D009108", "about": { "@type": "MedicalCondition", "name": "Vaccin antiourlien", "code": { "@type": "MedicalCode", "code": "D009108", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.488" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les papillomavirus", "alternateName": "Papillomavirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D053918", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les papillomavirus", "code": { "@type": "MedicalCode", "code": "D053918", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.498" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18", "alternateName": "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18", "url": "https://questionsmedicales.fr/mesh/D000068857", "about": { "@type": "MedicalCondition", "name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18", "code": { "@type": "MedicalCode", "code": "D000068857", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.498.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus para-influenza", "alternateName": "Parainfluenza Vaccines", "url": "https://questionsmedicales.fr/mesh/D022241", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus para-influenza", "code": { "@type": "MedicalCode", "code": "D022241", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.500" } } }, { "@type": "MedicalWebPage", "name": "Vaccins antipoliomyélitiques", "alternateName": "Poliovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D023321", "about": { "@type": "MedicalCondition", "name": "Vaccins antipoliomyélitiques", "code": { "@type": "MedicalCode", "code": "D023321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin antipoliomyélitique inactivé", "alternateName": "Poliovirus Vaccine, Inactivated", "url": "https://questionsmedicales.fr/mesh/D011054", "about": { "@type": "MedicalCondition", "name": "Vaccin antipoliomyélitique inactivé", "code": { "@type": "MedicalCode", "code": "D011054", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623.500" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antipoliomyélitique oral", "alternateName": "Poliovirus Vaccine, Oral", "url": "https://questionsmedicales.fr/mesh/D011055", "about": { "@type": "MedicalCondition", "name": "Vaccin antipoliomyélitique oral", "code": { "@type": "MedicalCode", "code": "D011055", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie d'Aujeszky", "alternateName": "Pseudorabies Vaccines", "url": "https://questionsmedicales.fr/mesh/D022421", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie d'Aujeszky", "code": { "@type": "MedicalCode", "code": "D022421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.632" } } }, { "@type": "MedicalWebPage", "name": "Vaccins antirabiques", "alternateName": "Rabies Vaccines", "url": "https://questionsmedicales.fr/mesh/D011819", "about": { "@type": "MedicalCondition", "name": "Vaccins antirabiques", "code": { "@type": "MedicalCode", "code": "D011819", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.700" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus respiratoires syncytiaux", "alternateName": "Respiratory Syncytial Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022261", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus respiratoires syncytiaux", "code": { "@type": "MedicalCode", "code": "D022261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.730" } } }, { "@type": "MedicalWebPage", "name": "Vaccins anti-rotavirus", "alternateName": "Rotavirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022243", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-rotavirus", "code": { "@type": "MedicalCode", "code": "D022243", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.760" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antirubéoleux", "alternateName": "Rubella Vaccine", "url": "https://questionsmedicales.fr/mesh/D012411", "about": { "@type": "MedicalCondition", "name": "Vaccin antirubéoleux", "code": { "@type": "MedicalCode", "code": "D012411", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.779" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre la rougeole, les oreillons et la rubéole", "alternateName": "Measles-Mumps-Rubella Vaccine", "url": "https://questionsmedicales.fr/mesh/D022542", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la rougeole, les oreillons et la rubéole", "code": { "@type": "MedicalCode", "code": "D022542", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.779.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le SIDA simien", "alternateName": "SAIDS Vaccines", "url": "https://questionsmedicales.fr/mesh/D018449", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le SIDA simien", "code": { "@type": "MedicalCode", "code": "D018449", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.790" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antivariolique", "alternateName": "Smallpox Vaccine", "url": "https://questionsmedicales.fr/mesh/D012900", "about": { "@type": "MedicalCondition", "name": "Vaccin antivariolique", "code": { "@type": "MedicalCode", "code": "D012900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.859" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les hépatites virales", "alternateName": "Viral Hepatitis Vaccines", "url": "https://questionsmedicales.fr/mesh/D014761", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les hépatites virales", "code": { "@type": "MedicalCode", "code": "D014761", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccins anti-hépatite A", "alternateName": "Hepatitis A Vaccines", "url": "https://questionsmedicales.fr/mesh/D022362", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-hépatite A", "code": { "@type": "MedicalCode", "code": "D022362", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955.395" } } }, { "@type": "MedicalWebPage", "name": "Vaccins anti-hépatite B", "alternateName": "Hepatitis B Vaccines", "url": "https://questionsmedicales.fr/mesh/D017325", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-hépatite B", "code": { "@type": "MedicalCode", "code": "D017325", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le virus du Nil occidental", "alternateName": "West Nile Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D053060", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le virus du Nil occidental", "code": { "@type": "MedicalCode", "code": "D053060", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.962" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antiamaril", "alternateName": "Yellow Fever Vaccine", "url": "https://questionsmedicales.fr/mesh/D022341", "about": { "@type": "MedicalCondition", "name": "Vaccin antiamaril", "code": { "@type": "MedicalCode", "code": "D022341", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.970" } } } ], "about": { "@type": "MedicalCondition", "name": "Vaccins antiviraux", "alternateName": "Viral Vaccines", "code": { "@type": "MedicalCode", "code": "D014765", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yukai Huang", "url": "https://questionsmedicales.fr/author/Yukai%20Huang", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Xiao Guo", "url": "https://questionsmedicales.fr/author/Xiao%20Guo", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Yuancheng Zhou", "url": "https://questionsmedicales.fr/author/Yuancheng%20Zhou", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China." } }, { "@type": "Person", "name": "Dongying Liu", "url": "https://questionsmedicales.fr/author/Dongying%20Liu", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Jingrui Mao", "url": "https://questionsmedicales.fr/author/Jingrui%20Mao", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Applying behaviour change models to policy-making: development and validation of the Policymakers' Information Use Questionnaire (POLIQ).", "datePublished": "2023-01-23", "url": "https://questionsmedicales.fr/article/36691025", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12961-022-00942-y" } }, { "@type": "ScholarlyArticle", "name": "Research can be integrated into public health policy-making: global lessons for and from Spanish economic evaluations.", "datePublished": "2022-06-18", "url": "https://questionsmedicales.fr/article/35717247", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12961-022-00875-6" } }, { "@type": "ScholarlyArticle", "name": "Strengthening Governance and Institutional Capacity at the Nutrition-Food Supply Policy Nexus Comment on \"What Opportunities Exist for Making the Food Supply Nutrition Friendly? A Policy Space Analysis in Mexico\".", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35964160", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.34172/ijhpm.2022.7325" } }, { "@type": "ScholarlyArticle", "name": "Food system policy making and innovation at the local level: Exploring the response of Australian local governments to critical food systems issues.", "datePublished": "2022-06-19", "url": "https://questionsmedicales.fr/article/35718947", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/hpja.626" } }, { "@type": "ScholarlyArticle", "name": "Understanding accelerators to improve SDG-related outcomes for adolescents-An investigation into the nature and quantum of additive effects of protective factors to guide policy making.", "datePublished": "2023-01-06", "url": "https://questionsmedicales.fr/article/36607964", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0278020" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://questionsmedicales.fr/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://questionsmedicales.fr/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Vaccins", "item": "https://questionsmedicales.fr/mesh/D014612" }, { "@type": "ListItem", "position": 5, "name": "Vaccins antiviraux", "item": "https://questionsmedicales.fr/mesh/D014765" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vaccins antiviraux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vaccins antiviraux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vaccins antiviraux", "description": "Comment diagnostiquer une infection virale ?\nQuels tests sont utilisés pour les vaccins antiviraux ?\nLes symptômes indiquent-ils un besoin de vaccin ?\nComment évaluer l'efficacité d'un vaccin ?\nLes tests de dépistage sont-ils nécessaires avant vaccination ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Policy+Making&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vaccins antiviraux", "description": "Quels symptômes nécessitent un vaccin antiviral ?\nLes effets secondaires des vaccins sont-ils fréquents ?\nComment distinguer une infection d'un effet secondaire ?\nLes symptômes varient-ils selon le type de vaccin ?\nLes symptômes d'une infection virale sont-ils similaires ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Policy+Making&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vaccins antiviraux", "description": "Comment les vaccins antiviraux préviennent-ils les infections ?\nÀ quel âge doit-on commencer la vaccination antivirale ?\nLes vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?\nLes vaccins protègent-ils contre toutes les souches virales ?\nQuelle est l'importance de la vaccination de masse ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Policy+Making&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vaccins antiviraux", "description": "Les vaccins antiviraux sont-ils des traitements ?\nQuels traitements sont disponibles après infection ?\nLes vaccins peuvent-ils réduire la gravité des symptômes ?\nLes traitements sont-ils nécessaires après vaccination ?\nLes vaccins antiviraux nécessitent-ils des traitements préventifs ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Policy+Making&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vaccins antiviraux", "description": "Quelles complications peuvent survenir après vaccination ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications post-vaccinales ?\nLes complications varient-elles selon le vaccin ?\nLes complications peuvent-elles affecter l'immunité ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Policy+Making&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vaccins antiviraux", "description": "Quels sont les facteurs de risque pour les infections virales ?\nLes antécédents médicaux influencent-ils la vaccination ?\nLes voyages augmentent-ils le risque d'infection ?\nLes personnes âgées ont-elles plus de risques ?\nLe mode de vie influence-t-il le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Policy+Making&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection virale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les vaccins antiviraux ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité." } }, { "@type": "Question", "name": "Les symptômes indiquent-ils un besoin de vaccin ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un vaccin ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils nécessaires avant vaccination ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un vaccin antiviral ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin." } }, { "@type": "Question", "name": "Les effets secondaires des vaccins sont-ils fréquents ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers." } }, { "@type": "Question", "name": "Comment distinguer une infection d'un effet secondaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de vaccin ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle." } }, { "@type": "Question", "name": "Les symptômes d'une infection virale sont-ils similaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue." } }, { "@type": "Question", "name": "Comment les vaccins antiviraux préviennent-ils les infections ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques." } }, { "@type": "Question", "name": "À quel âge doit-on commencer la vaccination antivirale ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance." } }, { "@type": "Question", "name": "Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin." } }, { "@type": "Question", "name": "Les vaccins protègent-ils contre toutes les souches virales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires." } }, { "@type": "Question", "name": "Quelle est l'importance de la vaccination de masse ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus." } }, { "@type": "Question", "name": "Les vaccins antiviraux sont-ils des traitements ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles après infection ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils réduire la gravité des symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination." } }, { "@type": "Question", "name": "Les traitements sont-ils nécessaires après vaccination ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination." } }, { "@type": "Question", "name": "Les vaccins antiviraux nécessitent-ils des traitements préventifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après vaccination ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques." } }, { "@type": "Question", "name": "Comment gérer les complications post-vaccinales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles." } }, { "@type": "Question", "name": "Les complications varient-elles selon le vaccin ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter l'immunité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les infections virales ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils la vaccination ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques." } }, { "@type": "Question", "name": "Les personnes âgées ont-elles plus de risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque." } } ] } ] }

Sous-catégories

36 au total
└─

Vaccins anti-adénovirus

Adenovirus Vaccines D062705 - D20.215.894.899.024
└─

Vaccins contre le SIDA

AIDS Vaccines D016915 - D20.215.894.899.050
└─

Vaccins contre la COVID-19

COVID-19 Vaccines D000086663 - D20.215.894.899.085
└─

Vaccins contre le cytomégalovirus

Cytomegalovirus Vaccines D022482 - D20.215.894.899.120
└─

Vaccins contre la dengue

Dengue Vaccines D053059 - D20.215.894.899.162
└─

Vaccins contre la maladie à virus Ebola

Ebola Vaccines D046129 - D20.215.894.899.205
└─

Vaccins contre les herpèsvirus

Herpesvirus Vaccines D022283 - D20.215.894.899.290
└─

Vaccins antigrippaux

Influenza Vaccines D007252 - D20.215.894.899.302
└─

Vaccins contre l'encéphalite japonaise

Japanese Encephalitis Vaccines D022321 - D20.215.894.899.320
└─

Vaccin contre la rougeole

Measles Vaccine D008458 - D20.215.894.899.404
└─

Vaccin antiourlien

Mumps Vaccine D009108 - D20.215.894.899.488
└─

Vaccins contre les papillomavirus

Papillomavirus Vaccines D053918 - D20.215.894.899.498
└─

Vaccins contre les virus para-influenza

Parainfluenza Vaccines D022241 - D20.215.894.899.500
└─

Vaccins antipoliomyélitiques

Poliovirus Vaccines D023321 - D20.215.894.899.623
└─

Vaccins contre la maladie d'Aujeszky

Pseudorabies Vaccines D022421 - D20.215.894.899.632
└─

Vaccins antirabiques

Rabies Vaccines D011819 - D20.215.894.899.700
└─

Vaccins contre les virus respiratoires syncytiaux

Respiratory Syncytial Virus Vaccines D022261 - D20.215.894.899.730
└─

Vaccins anti-rotavirus

Rotavirus Vaccines D022243 - D20.215.894.899.760
└─

Vaccin antirubéoleux

Rubella Vaccine D012411 - D20.215.894.899.779
└─

Vaccins contre le SIDA simien

SAIDS Vaccines D018449 - D20.215.894.899.790
└─

Vaccin antivariolique

Smallpox Vaccine D012900 - D20.215.894.899.859
└─

Vaccins contre les hépatites virales

Viral Hepatitis Vaccines D014761 - D20.215.894.899.955
└─

Vaccins contre le virus du Nil occidental

West Nile Virus Vaccines D053060 - D20.215.894.899.962
└─

Vaccin antiamaril

Yellow Fever Vaccine D022341 - D20.215.894.899.970
└─└─

Vaccin ChAdOx1 nCoV-19

ChAdOx1 nCoV-19 D000090985 - D20.215.894.899.085.063
└─└─

Ad26COVS1

Ad26COVS1 D000090984 - D20.215.894.899.085.125
└─└─

Vaccin contre la varicelle

Chickenpox Vaccine D019433 - D20.215.894.899.290.130
└─└─

Vaccins contre les virus herpès simplex

Herpes Simplex Virus Vaccines D022301 - D20.215.894.899.290.400
└─└─

Vaccins contre la maladie de Marek

Marek Disease Vaccines D022501 - D20.215.894.899.290.500
└─└─

Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 D000068857 - D20.215.894.899.498.500
└─└─

Vaccin antipoliomyélitique inactivé

Poliovirus Vaccine, Inactivated D011054 - D20.215.894.899.623.500
└─└─

Vaccin antipoliomyélitique oral

Poliovirus Vaccine, Oral D011055 - D20.215.894.899.623.750
└─└─

Vaccin contre la rougeole, les oreillons et la rubéole

Measles-Mumps-Rubella Vaccine D022542 - D20.215.894.899.779.500
└─└─

Vaccins anti-hépatite A

Hepatitis A Vaccines D022362 - D20.215.894.899.955.395
└─└─

Vaccins anti-hépatite B

Hepatitis B Vaccines D017325 - D20.215.894.899.955.400
└─└─└─

Vaccin contre le zona

Herpes Zoster Vaccine D053061 - D20.215.894.899.290.130.400

Sources (10000 au total)

Applying behaviour change models to policy-making: development and validation of the Policymakers' Information Use Questionnaire (POLIQ).

The purpose of this study was to develop and validate the Policymakers' Information Use Questionnaire (POLIQ) to capture the intention of individuals in decision-making positions, such as health polic... The development and validation comprised three steps: item generation, qualitative face validation with cognitive debriefing and factorial construct validation. Confirmatory factor analysis was applie... Cognitive debriefing allowed for small adjustments in language for clarity, including simultaneous validation of the English and French questionnaires. Participants found that the questions were clear... Measuring decision-makers' behaviour in relation to research evidence use is challenging. We provide initial evidence on face validity and appropriate measurement properties of the POLIQ based on a co...

Strengthening Governance and Institutional Capacity at the Nutrition-Food Supply Policy Nexus Comment on "What Opportunities Exist for Making the Food Supply Nutrition Friendly? A Policy Space Analysis in Mexico".

Cervantes et al have provided an insightful addition to the policy literature by identifying the contextual, political, and policy factors that create constraints and opportunities for putting nutriti...

Food system policy making and innovation at the local level: Exploring the response of Australian local governments to critical food systems issues.

Urgent action is required by all levels of government to create a food system capable of nourishing a rapidly growing population while remaining within planetary boundaries. This study investigated po... An online survey was completed by LGs (n = 64) in New South Wales and Victoria, Australia. Questions focused on LGs' food system-related policies and programs, barriers to and enablers of engaging in ... Preventing food waste, organising food-related social/cultural events and providing potable water were the most commonly reported activities. Few LGs reported policies/activities on market gardening o... Australian LGs undertake a wide range of actions addressing diverse food system issues; however, internal and external barriers constrain their involvement in creating a healthy, sustainable and equit...

Understanding accelerators to improve SDG-related outcomes for adolescents-An investigation into the nature and quantum of additive effects of protective factors to guide policy making.

Recent evidence has shown support for the United Nations Development Programme (UNDP) accelerator concept, which highlights the need to identify interventions or programmatic areas that can affect mul...

Embedding rapid reviews in health policy and systems decision-making: Impacts and lessons learned from four low- and middle-income countries.

Demand for rapid evidence-based syntheses to inform health policy and systems decision-making has increased worldwide, including in low- and middle-income countries (LMICs). To promote use of rapid sy... While the selected platforms had experience in health policy and systems research and evidence syntheses, platforms were less confident conducting rapid evidence syntheses. A technical assistance cent... Platforms provided rapid syntheses across a range of AHPSR themes, and successfully engaged national- and state-level policy-makers. Examples of substantial policy impact were observed, including for ... The ERA initiative successfully established rapid response platforms in four LMICs. The short timeframe limited the number of rapid products produced, but there were examples of substantial impact and...

Uncovering the Effect of European Policy-Making Initiatives in Addressing Nutrition-Related Issues: A Systematic Literature Review and Bibliometric Analysis on Front-of-Pack Labels.

The last decades have been marked by the introduction of front-of-pack labels (FoPL) as an institutional corrective action against obesity and nutrition-related illnesses. However, FoPL-related policy...

From Local Action to Global Policy: A Comparative Policy Content Analysis of National Policies to Address Musculoskeletal Health to Inform Global Policy Development.

Global policy to guide action on musculoskeletal (MSK) health is in a nascent phase. Lagging behind other non-communicable diseases (NCDs) there is currently little global policy to assist governments... Multi-modal search strategy incorporating a systematic online search targeted at the 30 most populated nations; a call to networked experts; a specified question in a related eDelphi questionnaire; an... The search yielded 165 documents with 41 retained after removal of duplicates and exclusions. Only three documents were comprehensive national strategies addressing MSK health. The most common conditi... There are few examples of national strategic policy to address MSK health; however, many countries are moving towards this by documenting the burden of disease and developing policies for MSK services...

Inclusion of people with disabilities in Chilean health policy: a policy analysis.

Around 18% of the population in Chile has disabilities. Evidence shows that this population has greater healthcare needs, yet they face barriers to accessing healthcare due to health system failures. ... A policy content analysis was conducted of 12 health policy documents using the EquiFrame framework, adapted to assess disability inclusion. Documents were reviewed and rated on their quality of commi... Core human rights concepts of disability were mentioned at least once in nearly all health policy documents (92%). However, 50% had poor policy commitments for disability. Across policies, Prevention ... Improvements are needed in both the development and implementation of disability-inclusive health policies in Chile, to support the achievement of the right to healthcare for people with disabilities ...

Understanding successful policy innovation: The case of Portuguese drug policy.

In 2000, the Portuguese minority socialist government decriminalized the possession and consumption of drugs. This law made Portugal unique in having a formal system that directs the person using drug... After discussing the limitations of the existing literature, we present a new theoretical framework: the 'six-stars' framework. We argue that successful policy innovation in democracies will only occu... The proposed 'six-stars' framework of successful drug policy innovation shows the importance of electoral mandates, communication, inclusion, transparency, deliberation and evaluation when designing i...